Maravai LifeSciences Holdings, Inc.
MRVI
$2.45
$0.062.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.59M | -29.95M | -26.15M | -99.04M | -9.79M |
| Total Depreciation and Amortization | 15.39M | 14.91M | 14.53M | 14.04M | 14.55M |
| Total Amortization of Deferred Charges | 391.00K | 461.00K | 658.00K | 754.00K | 744.00K |
| Total Other Non-Cash Items | 12.41M | -306.00K | 6.34M | 91.58M | 5.76M |
| Change in Net Operating Assets | 1.14M | 5.49M | -10.01M | 5.80M | 6.17M |
| Cash from Operations | -10.27M | -9.39M | -14.64M | 13.14M | 17.43M |
| Capital Expenditure | -2.87M | -5.24M | -5.85M | -8.59M | -9.55M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -362.00K | -18.63M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 734.00K | 918.00K | -368.00K | 3.37M |
| Cash from Investing | -3.24M | -23.13M | -4.93M | -8.96M | -6.18M |
| Total Debt Issued | -- | -- | 953.00K | -- | -- |
| Total Debt Repaid | -1.55M | -1.54M | -230.49M | -1.52M | -1.51M |
| Issuance of Common Stock | 13.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -4.73M | -602.00K | -19.00K | -28.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 1.38M | -6.05M | 2.35M | 1.76M |
| Cash from Financing | -1.53M | -4.90M | -236.19M | 809.00K | 228.00K |
| Foreign Exchange rate Adjustments | -111.00K | 73.00K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.15M | -37.35M | -255.76M | 4.99M | 11.48M |